Provided by Tiger Trade Technology Pte. Ltd.

Voyager Therapeutics

3.41
+0.01500.44%
Volume:236.38K
Turnover:794.67K
Market Cap:209.81M
PE:-1.88
High:3.42
Open:3.39
Low:3.24
Close:3.39
52wk High:5.55
52wk Low:2.94
Shares:61.62M
Float Shares:44.40M
Volume Ratio:0.54
T/O Rate:0.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8121
EPS(LYR):-2.0400
ROE:-54.09%
ROA:-27.34%
PB:1.36
PE(LYR):-1.67

Loading ...

Analyst Reaffirms Buy on Voyager Therapeutics as Strong Cash Runway and Advancing Neurology Pipeline Set Up Multiple 2026 Catalysts

TIPRANKS
·
May 08

Voyager Therapeutics reports Q1 EPS (47c), consensus (53c)

TIPRANKS
·
May 08

Voyager Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 08

Voyager Q1 net loss narrows to $27.9 million; revenue drops to $2.6 million

Reuters
·
May 08

BRIEF-Voyager Therapeutics Q1 Collaboration Revenue USD 2.593 Million

Reuters
·
May 08

Voyager Therapeutics Inc expected to post a loss of 53 cents a share - Earnings Preview

Reuters
·
May 01

H.C. Wainwright Reaffirms Their Buy Rating on Voyager Therapeutics (VYGR)

TIPRANKS
·
Apr 29

Voyager plans IND filing for Alzheimer’s gene therapy VY1706 in Q2 2026

Reuters
·
Apr 28

BRIEF-Voyager Therapeutics Inc - Nathan Jorgensen Resigns As CFO Effective May 8, 2026

Reuters
·
Apr 22

Voyager Therapeutics Announces CFO Resignation and Finance Leadership Changes

TIPRANKS
·
Apr 22

Voyager Therapeutics Inc - Nathan Jorgensen Resigns as CFO Effective May 8, 2026 - SEC Filing

THOMSON REUTERS
·
Apr 22

CORRECTED-Amazon launches AI research tool to speed early-stage drug discovery

Reuters
·
Apr 14

Voyager Therapeutics management to meet with Oppenheimer

TIPRANKS
·
Apr 11

Voyager Therapeutics announces annual shareholder meeting agenda includes authorized share increase vote

Reuters
·
Apr 11

Top Executive at Voyager Therapeutics Makes Notable Stock Move

TIPRANKS
·
Apr 04

Voyager Therapeutics: Early-Stage Tau Program Optionality Drives High-Risk, High-Upside Buy Rating

TIPRANKS
·
Mar 24

Voyager Therapeutics Price Target Maintained With a $25.00/Share by HC Wainwright & Co.

Dow Jones
·
Mar 18

Voyager Therapeutics: Differentiated CNS Platform, Strategic Partnerships, and 2026 Data Catalysts Underpin Buy Rating

TIPRANKS
·
Mar 18

Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (MMSI), Voyager Therapeutics (VYGR) and Structure Therapeutics, Inc. Sponsored ADR (GPCR)

TIPRANKS
·
Mar 17

Voyager Therapeutics: Advancing Tau-Targeted Gene Therapy with Multiple Near-Term Catalysts and Attractive Risk-Reward

TIPRANKS
·
Mar 12